వెతకండి (వార్తలు)

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored By International Myeloma Foundation Leaders Provides Evidence For Optimal Duration Of Maintenance Therapy

english top health

(MENAFN - GlobeNewsWire - Nasdaq) STUDIO CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Study results from the randomized, prospective phase III ENDURANCE (E1A11) trial, designed and conducted by ...
2026-07-15 17:03:03